Table 2.
Clinical and biological characteristics of 92 CLL patients
| Characteristic | Value (%) |
|---|---|
| Sex (n=92) | |
| Male | 57 (61.96) |
| Female | 35 (38.04) |
| Age (n=92) | |
| ≥60 | 50 (54.35) |
| <60 | 42 (45.65) |
| Binet stage (n=92) | |
| A | 37 (40.22) |
| B | 22 (23.91) |
| C | 33 (35.87) |
| CD38 (n=88) | |
| ≥30% | 22 (25.00) |
| <30% | 66 (75.00) |
| ZAP70 (n=87) | |
| ≥20% | 23 (26.44) |
| <20% | 64 (73.56) |
| IGHV (n=78) | |
| Mutated (>2% deviation from a germline) | 51 (65.38) |
| Unmutated (≤2% deviation from a germline) | 27 (34.62) |
| p53 mutation status (n=86) | |
| Presence | 17 (19.77) |
| Absence | 69 (80.23) |
| Cytogenetics (n=92) | |
| del (17p13) or del (11q22.3) | 26 (28.26) |
| del (13q14) as the sole abnormality | 6 (6.52) |
| others | 60 (65.22) |